Where to Get Retatrutide (Reta) in Canada
Weight Loss & Metabolism Research
The honest answer to “where can I get retatrutide in Canada” has three parts: what reta actually is right now, who can lawfully supply it, and how to tell a real supplier from a label. Here is all three, without the usual vendor-listicle padding.
What retatrutide is in 2026
Retatrutide — “reta” — is a triple receptor agonist (GLP-1, GIP and glucagon) still in clinical development. It is not approved by Health Canada or any other regulator. That single fact defines the entire supply landscape: no pharmacy carries it, no prescription exists for it, and anything sold in Canada is supplied strictly as a research material for laboratory use.
The two routes, and why one of them keeps failing
Route one: order from a US or overseas vendor. The package crosses the border, and unapproved drugs are exactly the category CBSA is entitled to hold or seize. Community forums through 2026 describe seizures concentrated at west-coast entry points, group orders lost in bulk, and vendors that explicitly exclude Canada from shipping insurance. A seized vial is not replaced; the money is simply gone.
Route two: order from a supplier already inside Canada. No border, no CBSA, no seizure category — the parcel travels like any domestic delivery. This is why Canadian research buyers have moved sharply toward domestic suppliers.
How to vet any supplier, including us
- Certificate of analysis. A third-party lab’s record of identity and purity — the only substantiation that counts.
- Named sizes and real specifications. Reta circulates as lyophilised powder, typically 10–30 mg vials. Vague listings are a signal.
- Domestic dispatch you can verify. Canadian tracking from a Canadian origin, not “ships worldwide.”
- Plain research-use framing. A supplier making medical claims about an unapproved compound is telling you how carefully they operate.
Vistara Labs supplies retatrutide (reta) in 10 mg and 20 mg lyophilised vials, third-party tested with COAs available on request, shipped from within Canada to every province. Payment by Interac e-Transfer; orders over $150 ship free.
Frequently asked questions
Is retatrutide available in Canada?
As a research material, yes — supplied by Canadian research vendors for laboratory use only. It is not available as a medicine anywhere, because it has no regulatory approval yet.
Will my order go through customs?
Only if you order from outside the country. A domestic order from Vistara Labs never crosses a border.
How do I confirm what is in the vial?
By the certificate of analysis. Vistara Labs has one for every product, available on request.
All products supplied by Vistara Labs are intended for laboratory research use only. They are not drugs, are not approved for human or veterinary use, and are not intended to diagnose, treat, cure or prevent any condition. Nothing on this page constitutes medical advice or guidance for use in humans.
References
Retatrutide has been evaluated in randomised, placebo-controlled human trials through phase 3.
- Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 TrialRandomised, double-blind, placebo-controlled phase 2 obesity trial, 48 weeks.
- Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USARandomised, double-blind, placebo- and active-controlled phase 2 trial; 281 participants with type 2 diabetes.
- Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trialRandomised phase 2a substudy; 98 participants with metabolic dysfunction-associated steatotic liver disease.
- Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 trialDouble-blind randomised phase 3 trial in type 2 diabetes (TRANSCEND-T2D-1).
Links open the study record on PubMed so the source can be checked directly. Listing a study is not a claim that its findings apply to any other use, product or route of administration. Research use only.
